Locally advanced head and neck cancer
- PMID: 23714512
- DOI: 10.14694/EdBook_AM.2013.33.237
Locally advanced head and neck cancer
Abstract
Treatment of locally advanced head and neck squamous cell carcinomas requires a multidisciplinary approach to be able to offer patients definitive therapy while aiming to preserve organ function and minimize acute and long-term toxicities. Advances in surgical techniques will be reviewed for both primary sites and the neck and also in the salvage settings. Recent data on concurrent versus sequential chemoradiotherapy in these patients will be reviewed, with emphasis on identification of appropriate patients for sequential chemoradiotherapy. Finally, advances in modern radiotherapy modalities that have resulted in improved dosimetry and quality of life following treatment will be reviewed.
Similar articles
-
Prospective Study of Cetuximab, Carboplatin, and Radiation Therapy for Patients With Locally Advanced Head and Neck Squamous Cell Cancer Unfit for Cisplatin.Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):948-954. doi: 10.1016/j.ijrobp.2017.02.088. Epub 2017 Feb 24. Int J Radiat Oncol Biol Phys. 2017. PMID: 28483336 Clinical Trial.
-
Single-Arm Phase 2 Trial of Elective Nodal Dose Reduction for Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck.Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1210-1216. doi: 10.1016/j.ijrobp.2017.12.277. Epub 2017 Dec 28. Int J Radiat Oncol Biol Phys. 2018. PMID: 29452770 Free PMC article. Clinical Trial.
-
Phase 2 study of docetaxel, cisplatin, and concurrent radiation for technically resectable stage III-IV squamous cell carcinoma of the head and neck.Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):934-41. doi: 10.1016/j.ijrobp.2014.12.032. Int J Radiat Oncol Biol Phys. 2015. PMID: 25832686 Clinical Trial.
-
ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas.Head Neck. 2016 Sep;38(9):1299-309. doi: 10.1002/hed.24447. Epub 2016 Jun 22. Head Neck. 2016. PMID: 27330003 Review.
-
Chemotherapy in locally advanced head and neck squamous cell carcinoma.Cancer Treat Rev. 2016 Mar;44:10-6. doi: 10.1016/j.ctrv.2016.01.002. Epub 2016 Jan 22. Cancer Treat Rev. 2016. PMID: 26924194 Review.
Cited by
-
DNA methylation biomarkers for head and neck squamous cell carcinoma.Epigenetics. 2018;13(4):398-409. doi: 10.1080/15592294.2018.1465790. Epub 2018 Aug 10. Epigenetics. 2018. PMID: 29927694 Free PMC article.
-
NTF2 Upregulation in HNSCC: a Predictive Marker and Potential Therapeutic Target Associated With Immune Infiltration.Front Oncol. 2022 Jun 17;12:783919. doi: 10.3389/fonc.2022.783919. eCollection 2022. Front Oncol. 2022. PMID: 35785175 Free PMC article.
-
Clinical and scientific impact of human papillomavirus on head and neck cancer.World J Clin Oncol. 2014 Oct 10;5(4):781-91. doi: 10.5306/wjco.v5.i4.781. World J Clin Oncol. 2014. PMID: 25302178 Free PMC article. Review.
-
Survival Outcomes and Factors Affecting Survival in Resectable Locally Advanced Oral Squamous Cell Carcinoma.Indian J Otolaryngol Head Neck Surg. 2023 Jun;75(2):607-616. doi: 10.1007/s12070-022-03404-7. Epub 2022 Dec 19. Indian J Otolaryngol Head Neck Surg. 2023. PMID: 37275034 Free PMC article.
-
The association, clinicopathological significance, and diagnostic value of CDH1 promoter methylation in head and neck squamous cell carcinoma: a meta-analysis of 23 studies.Onco Targets Ther. 2016 Oct 31;9:6763-6773. doi: 10.2147/OTT.S117453. eCollection 2016. Onco Targets Ther. 2016. PMID: 27826202 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical